The Study
Genetic insights into biological aging and myasthenia gravis: a Mendelian randomization study of telomere length, epigenetic clocks, and mitochondrial DNA copy number
This study didn't test people directly—it used computer math on genetic data from other studies to guess if aging might be linked to a disease called MG. It found some hints, but they're not strong enough to say one thing causes the other—just that they might be connected.
Analysis score
Maximum 0 for a computational/algorithm study.
Where the score came from
This study used genetic data to see if how fast your body ages affects whether you get a rare muscle disease called myasthenia gravis.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 50 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1For young people, a more active immune system (linked to younger biological age) may trigger the disease, but once it starts, it speeds up aging.
- 2For older people, mitochondrial stress may be a key factor.
- 3Younger biological age (measured by HannumAge) increases risk of early-onset MG by 22.5%.
- 4The disease itself then makes your body age faster by 10%.
- 5Higher mitochondrial DNA levels are linked to a 75.6% higher risk of late-onset MG.
- 6Telomere length doesn't matter for this disease.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Clinical Epigenetics
Year
2026
Authors
Wei Xiang, Yining Luan, Kangzhi Chen, Ting He, Qian Zhou, Huan Yang
Related Content
Claims (5)
People with genetic patterns that predict faster biological aging, as measured by the HannumAge epigenetic clock, have a 22.5% lower risk of developing early-onset myasthenia gravis compared to those with slower biological aging, based on data from individuals of European ancestry.
In people who develop myasthenia gravis later in life, DNA methylation patterns that estimate biological age do not show a meaningful link to the disease, suggesting that accelerated aging measured this way is not a main factor in this form of the condition.
People with early-onset myasthenia gravis show a 9.8% to 10.0% higher rate of epigenetic aging, as measured by GrimAge and HannumAge, compared to those without the condition, and this difference is related to ongoing inflammation and immune system activity.
People with late-onset myasthenia gravis have 75.6% higher mitochondrial DNA copy numbers compared to those without the disease, and this increase is linked to ongoing oxidative stress in aging.
Telomere length is not linked to myasthenia gravis, and shortening of telomeres does not primarily drive the autoimmune process in this disease.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.